ProShare Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Sell |
12,029
-1,067
| -8% | -$46.6K | ﹤0.01% | 1099 |
|
|
2025
Q1 | $358K | Sell |
13,096
-3,197
| -20% | -$87.5K | ﹤0.01% | 1293 |
|
|
2024
Q4 | $655K | Buy |
16,293
+4,071
| +33% | +$164K | ﹤0.01% | 1122 |
|
|
2024
Q3 | $578K | Buy |
12,222
+2,972
| +32% | +$141K | ﹤0.01% | 1059 |
|
|
2024
Q2 | $276K | Sell |
9,250
-2,359
| -20% | -$70.4K | ﹤0.01% | 1345 |
|
|
2024
Q1 | $467K | Buy |
11,609
+1,775
| +18% | +$71.4K | ﹤0.01% | 1134 |
|
|
2023
Q4 | $250K | Buy |
+9,834
| New | +$250K | ﹤0.01% | 1506 |
|
|
2023
Q2 | – | Sell |
-8,276
| Closed | -$245K | – | 1879 |
|
|
2023
Q1 | $245K | Sell |
8,276
-1,121
| -12% | -$33.2K | ﹤0.01% | 1324 |
|
|
2022
Q4 | $235K | Buy |
+9,397
| New | +$235K | ﹤0.01% | 1383 |
|
|
2022
Q2 | – | Sell |
-11,790
| Closed | -$499K | – | 1969 |
|
|
2022
Q1 | $499K | Sell |
11,790
-2,953
| -20% | -$125K | ﹤0.01% | 1276 |
|
|
2021
Q4 | $935K | Buy |
14,743
+10,338
| +235% | +$656K | ﹤0.01% | 1060 |
|
|
2021
Q3 | $259K | Sell |
4,405
-3,094
| -41% | -$182K | ﹤0.01% | 1651 |
|
|
2021
Q2 | $364K | Buy |
+7,499
| New | +$364K | ﹤0.01% | 1760 |
|